Addressing the causes of non-adherence to deliver medicine counselling services at community level

Case Studies / Adherance Support & Behaviour Change

Working with Pfizer to create user-led tools to promote more effective patient-provider communication. Creating digital and print learning packages to show patients on long-term prescribed drugs why it’s important to take them.


Medicines play a crucial role in maintaining health, preventing illness, managing chronic conditions and curing disease. In the UK it is estimated that one billion medicines are wasted every year and one in five patients do not complete their prescribed course of medication, with non-adherence costing the NHS £500m each year.1

In the US, the New York Times described non-adherence as an “out of control epidemic” costing the US more than any other disease entity.2

The causes of non-adherence are both practical and psychological and research supports the positive impact of pharmacy-based interventions.


Studio Health has worked with academics, researchers and practising healthcare professionals to develop digital and physical learning packages to support community pharmacy deliver medicines counselling services. These have been developed for use in both high and low to middle income country settings and use educational interventions and evidence-based strategies to deal with community issues such as low health literacy and health inequalities as well as medicines use challenges including adherence and benefit risk communication.


The digital and physical learning packages include educational videos, a webcast series, and workshop materials and have been used across Europe, in the US, Africa and India by over 6000 community pharmacists.

  1. Hagan P. The true cost of medication non-adherence. Omnicell UK — adherence let’s take care of it campaign 2015. Available at (accessed May 2019) ↩︎

  2. Brody J. The cost of not taking your medicine. The New York Times 17 April 2017. Available at: (accessed May 2019) ↩︎